Info: Ancillary Studies to the Ad Neuroimaging Initiative

Ancillary Studies to the Ad Neuroimaging Initiative

Published on AidPage by IDILOGIC on Jun 24, 2005

Data sources: Catalog of Federal Domestic Assistance (CFDA), Grants.gov

Administered by:

Department of Health and Human Services, National Institutes of Health, National Institutes of Health
(see all US Federal Agencies)

Explore all postings for this grant program:

Original Grant - Sep 29, 2004

Applications Due:

Multiple Receipt Dates - See Link to Full Announcement for details.

total funding:	Not Available
max award:	$50,000
min award:	none
cost sharing, matching:	No
number of awards:	Not Available
type of funding:	Grant

Description:

This PA invites research grant applications for ancillary studies to the Alzheimers Disease Neuroimaging Initiative (ADNI), a multi-site, longitudinal, prospective, naturalistic study of normal cognitive aging, mild cognitive impairment (MCI), and early Alzheimer's disease (AD). The ADNI will collect, process, and store serial blood, CSF, and urine samples in the three groups for analyses for potential biomarkers of disease progression, including genomic, proteomic, and metabolomic markers that can be correlated with clinical, neuropsychological, and imaging data. Immortalized cell lines will also be established.

The ancillary studies may propose and measure potential biomarkers, or offer new approaches to analyzing the dataset (e.g., image processing techniques, statistical analysis), or develop parallel neuroimaging studies with a different sample but with a subset of the measures used in the ADNI protocol, or propose autopsy studies.